HDMA - >New Research Now Available: Rules Of Engagement: Phase 2 • The Blueprint for Data Management & Data Sharing

Anti-Counterfeiting Controlled Substances Emergency Preparedness Flu Vaccine HDMA PAC HDMA State LawBooks Log Into HDMA State LawBooks Importation Internet Pharmacy Legislative Center Patient Privacy and Confidentiality Prescription Drug Pedigree Requirements Tax Legislation Additional HDMA Federal Agency Activities News Center Press Room Vital Link Annual Leadership Forum Distribution Management Conference & Expo Business Partners Exchange Regional Roundtable Meetings RFID/Track & Trace Health Care Summit Upcoming Meetings & Conferences Webinars Education Webinars Seminars Anti-Counterfeiting Barcoding Biotechnology Contract
Administration/Chargebacks Controlled Substances Ordering
System (CSOS) Electronic Data Interchange (EDI) Electronic Product Code (EPC) Product Availability/Drug Shortages HDMA Distribution Digest HDMA New Rx Product Introduction Form HDMA State LawBooks Log Into HDMA State LawBooks Industry Acronyms Industry Analysts Industry News Links Industry Statistics Industry Web Links Links to State Legislatures Award Programs Member Companies HDMA Directory HDMA Antitrust Policy Sponsorship Opportunities Advertising Opportunities



> HDMA Testifies Supporting HR5839 > HDMA Applauds Introduction of HR 5839 > HDMA Applauds NCPA, FBI LEEDA and Purdue Pharma > HDMA Commends California Board of Pharmacy Decision > New Data Management & Sharing Research Now Available! print page

New Research Now Available: Rules Of Engagement:
Phase II • The Blueprint for Data Management
& Data Sharing

The Center for Healthcare Supply Chain Research, HDMA’s knowledge partner, is pleased to announce the release of Rules of Engagement: Phase II • The Blueprint for Data Management & Data Sharing. This ground-breaking research presents a future vision for tracking and tracing prescription medicines from the beginning to the end of the healthcare supply chain, and outlines the technologies and steps that can enable companies to share and manage item-level product data.

The Blueprint recommends a phased approach to data management and data sharing. Companies that adopt Level 1 of the Blueprint can share data point-to-point, working to achieve compliance with current and emerging pedigree requirements while building a foundation to extend data sharing capabilities in the future. Companies that move to Level 2 can share product shipment and location data on-demand, using analytics software to further enhance supply chain efficiency. At Level 3, companies can use a global registry to share shipment, location and order pattern data. At this level, companies can have a far broader picture of supply chain activity, and trading partners may be better able to work together to enhance monitoring for potentially suspicious events that may be an early warning sign of counterfeiting, diversion, theft or other criminal activities. All three levels of deployment are based on third-party standards.

The strategic path forward, described in the Blueprint, takes into account the variability of technology systems across the supply chain and is designed to accommodate companies with advanced IT capabilities, as well as those that lack the capital for major technology investments. Each level is based on incremental, ongoing investments, and can be customized to meet individual company needs.

Rules of Engagement: Phase II • The Blueprint for Data Management & Data Sharing also describes efficiency and other business process improvements that may result from the implementation of the Blueprint. In following a common path forward using interoperable, open systems, research indicates that the costs of deployment can decrease and that greater numbers of supply chain partners can participate in the effort to share and manage item-level track-and-trace data. With increased data sharing across the supply chain, research suggests that companies may be able to enhance their trading partner relationships and work more effectively to pinpoint and correct process inefficiencies and achieve potentially significant operational gains.

The Center would like to thank the following companies for their support of this research initiative: AmerisourceBergen Drug Company; Apotex Corp.; Axway, Inc; Baxter Healthcare; Cardinal Health, Inc.; Centocor, Inc.; Cephalon, Inc.; Edge Dynamics; Eisai, Inc.; Genentech, Inc.; GHX; GlaxoSmithKline; H.D. Smith; IBM Corporation; Johnson & Johnson; McKesson Supply Solutions; MedPointe Healthcare, Inc.; Ortho-Biotech Products, L.P.; Ortho-McNeil Janssen Pharmaceutical Services; Pfizer, Inc.; Procter & Gamble Pharmaceuticals; Ranbaxy Pharmaceuticals, Inc.; Scios, Inc.; Upsher-Smith Laboratories, Inc; US Oncology Specialty, LP; and Wyeth Pharmaceuticals.

To order Rules of Engagement: Phase II • The Blueprint for Data Management & Data Sharing, please click here.

For more information, please contact Karen Ribler, EVP & COO, Center for Healthcare Supply Chain Research, at 703-885-0256 or e-mail kribler@hdmanet.org.